| Serial Number | 90603920 |
| Word Mark | BYKRASO |
| Filing Date | Thursday, March 25, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, November 21, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 22, 2022 |
| Goods and Services | pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors |
| Goods and Services | research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 1, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 1, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Mirati Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | Mirati Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Event Date | Event Description |
| Monday, November 21, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, November 21, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, April 19, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 22, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 22, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 2, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 18, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, January 15, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Saturday, January 15, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Saturday, January 15, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Saturday, January 15, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, December 20, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, December 20, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 20, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 9, 2021 | ASSIGNED TO LIE |
| Monday, November 8, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, November 8, 2021 | NON-FINAL ACTION E-MAILED |
| Monday, November 8, 2021 | NON-FINAL ACTION WRITTEN |
| Monday, November 1, 2021 | ASSIGNED TO EXAMINER |
| Thursday, July 1, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, June 30, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, June 30, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, June 30, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, March 29, 2021 | NEW APPLICATION ENTERED |